Lei An

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Intellectual Disability

Small Cell Lung Cancer

Tyrosine Kinase

Atomic Force Microscopy

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

This page only lists publications with an associated author ORCID identifier.

Publications

Xiangkai Wei, Guoliang Zhang, Qian Liu, Zhiyuan Niu, Chunhong Chu, Chenxue Liu, Ke Wang, Lanxin Li, Rui Wang, Wenrui Cui, Huixia Xu, Chenyang Liu, Ying Wang, Lei An
Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Lu Mao, Yueqiang Wang, Lei An, Beiping Zeng, Yanyan Wang, Dmitrij Frishman, Mengli Liu, Yanyu Chen, Wenxue Tang, Hongen Xu
Molecular Mechanisms and Clinical Phenotypes of GJB2 Missense Variants. Biology 12 (4) (2023)
Chang Liu, Zhenxing Wang, Qian Liu, Guangyao Wu, Chunhong Chu, Lanxin Li, Lei An, Shaofeng Duan
Correction to: Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Lu Mao, Yueqiang Wang, Lei An, Beiping Zeng, Yanyan Wang, Dmitrij Frishman, Mengli Liu, Yanyu Chen, Wenxue Tang, Hongen Xu
Molecular Mechanisms and Clinical Phenotypes of GJB2 Missense Variants. Biology 12 (4) (2023)
Chang Liu, Zhenxing Wang, Qian Liu, Guangyao Wu, Chunhong Chu, Lanxin Li, Lei An, Shaofeng Duan
Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (10) (2022)